PERJETA (Genentech, Inc.)


Welcome to the PulseAid listing for the PERJETA drug offered from Genentech, Inc.. This HER2 Receptor Antagonist [EPC],HER2/Neu/cerbB2 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Genentech, Inc.
NON-PROPRIETARY NAME: Pertuzumab
SUBSTANCE NAME: PERTUZUMAB
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: HER2 Receptor Antagonist [EPC],HER2/Neu/cerbB2 Antagonists [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2012-06-08
END MARKETING DATE: 0000-00-00


PERJETA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPERJETA from Genentech, Inc.
LABELER NAME: Genentech, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 30(mg/mL)
START MARKETING DATE: 2012-06-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50242-145_c81082a7-672d-400c-972b-0dfd4baa20fe
PRODUCT NDC: 50242-145
APPLICATION NUMBER: BLA125409

Other PERTUZUMAB Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Genentech, Inc.PERJETA